Nanobiotix SA (NANO):企業の財務・戦略的SWOT分析

【英語タイトル】Nanobiotix SA (NANO) - Financial and Strategic SWOT Analysis Review

・産業分野:Pharmaceuticals and Healthcare
Site License(同一事業所内共有可)USD600 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥103,500見積依頼/購入/質問フォーム

Nanobiotix SA (Nanobiotix) designs and manufactures nanomedicines for the treatment of cancer. The company is evaluating its lead product candidate NBTXR3 against soft tissue sarcoma, pancreatic, liver, rectal, prostate, head and neck cancers; Non-small cell lung cancer (NSCLC); recurrent head and neck, lung or liver metastasis. Its product candidate consists of nanoparticles delivered through one time intratumoral injection and are activated by radiation therapy. The company is a spin-off from the University of Buffalo in New York. It has operations in the US, Spain and Germany. Nanobiotix is headquartered in Paris, Ile-de-France, France

Nanobiotix SA Key Recent Developments

Mar 17,2021: NANOBIOTIX Reports Full Year 2020 Financial Results and Highlights Operational Progress
Mar 02,2021: NANOBIOTIX: Preclinical data presented at first AACR virtual special conference on radiation science and medicine showed NBTXR3 combo overcomes anti-PD-1 resistance, promotes strong abscopal effect and long-term anti-cancer memory
Jan 28,2021: NANOBIOTIX announces first patient injected with NBTXR3 in esophageal cancer

This comprehensive SWOT profile of Nanobiotix SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Nanobiotix SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table of Contents

Section 1 – About the Company

Nanobiotix SA – Key Information
Nanobiotix SA – Overview
Nanobiotix SA – Key Employees
Nanobiotix SA – Key Employee Biographies
Nanobiotix SA – Key Operational Heads
Nanobiotix SA – Major Products and Services
Nanobiotix SA – History
Nanobiotix SA – Company Statement
Nanobiotix SA – Locations And Subsidiaries
Nanobiotix SA
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Nanobiotix SA – Business Description
Nanobiotix SA – Corporate Strategy
Nanobiotix SA – SWOT Analysis
SWOT Analysis – Overview
Nanobiotix SA – Strengths
Nanobiotix SA – Weaknesses
Nanobiotix SA – Opportunities
Nanobiotix SA – Threats
Nanobiotix SA – Key Competitors

Section 3 – Company Financial Performance Charts

Nanobiotix SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Nanobiotix SA, Key Information
Nanobiotix SA, Key Ratios
Nanobiotix SA, Share Data
Nanobiotix SA, Major Products and Services
Nanobiotix SA, History
Nanobiotix SA, Key Employees
Nanobiotix SA, Key Employee Biographies
Nanobiotix SA, Key Operational Heads
Nanobiotix SA, Other Locations
Nanobiotix SA, Subsidiaries
Nanobiotix SA, Key Competitors
Nanobiotix SA, SWOT Analysis
Nanobiotix SA, Ratios based on current share price
Nanobiotix SA, Annual Ratios
Nanobiotix SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★調査レポート[Nanobiotix SA (NANO):企業の財務・戦略的SWOT分析] (コード:GDPH87155FSA)販売に関する免責事項を必ずご確認ください。
★調査レポート[Nanobiotix SA (NANO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ